Kangji Medical Holdings Limited
SZSC:9997 Stok Raporu
Kangji Medical Holdings Gelecekteki Büyüme
Future kriter kontrolleri 3/6 Kangji Medical Holdings kazanç ve gelirinin sırasıyla yıllık 14.3% ve 15.9% oranında artması tahmin edilirken, EPS'nin yıllık 14.3% oranında büyümesi bekleniyor.
Anahtar bilgiler Medical Equipment kazanç büyümesi 40.1% Gelir büyüme oranı 15.9% Gelecekteki özkaynak getirisi n/a Analist kapsamı Low
Son güncelleme 21 Aug 2024
Gelecekteki son büyüme güncellemeleri
Tüm güncellemeleri göster
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Sep 27
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024 Aug 06 Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024
Investor sentiment deteriorates as stock falls 26% May 29
Upcoming dividend of CN¥1.40 per share May 22
Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022) Apr 30
Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 Apr 26
Dividend of CN¥1.40 announced Mar 22 Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024
Investor sentiment improves as stock rises 17% Nov 08
Kangji Medical Holdings Limited Announces CFO Changes Sep 06 Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023
First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022) Aug 31
Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
Now 21% undervalued after recent price drop Aug 01
Now 22% undervalued after recent price drop Jul 05
Now 20% undervalued after recent price drop Jun 12
Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023 May 26
Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.37 in FY 2021) Mar 29
Investor sentiment improved over the past week Jan 16
Less than half of directors are independent Nov 16
First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022 Aug 03
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022 May 27
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021 May 26
Upcoming dividend of HK$0.17 per share May 20
Kangji Medical Holdings Limited Announces Executive Changes May 04
Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020) May 03
Less than half of directors are independent Apr 27
Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022 Mar 03
Investor sentiment deteriorated over the past week Dec 07
Investor sentiment improved over the past week Sep 02
First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020) Aug 29
Investor sentiment improved over the past week Aug 03
Investor sentiment improved over the past week Jul 16
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020 May 27
Investor sentiment improved over the past week May 17
Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.20 in FY 2019) Apr 28
Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020 Apr 27
Investor sentiment improved over the past week Apr 24
Full year 2020 earnings released Mar 26
Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021 Mar 13
Investor sentiment deteriorated over the past week Feb 27
New 90-day low: HK$10.88 Feb 27
Investor sentiment deteriorated over the past week Jan 29
New 90-day low: HK$12.16 Jan 28
Investor sentiment deteriorated over the past week Dec 24
New 90-day low: HK$13.86 Dec 09
Market pulls back on stock over the past week Nov 26
Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director Nov 06
First half earnings released Sep 22
Kazanç ve Gelir Büyüme Tahminleri SZSC:9997 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions ) Tarih Gelir Kazançlar Serbest Nakit Akışı Faaliyetlerden Nakit Avg. Analist Sayısı 12/31/2026 1,468 772 N/A N/A 1 12/31/2025 1,239 651 N/A N/A 2 12/31/2024 1,067 575 N/A N/A 2 6/30/2024 981 534 373 472 N/A 3/31/2024 953 519 353 446 N/A 12/31/2023 926 504 333 420 N/A 9/30/2023 892 540 312 390 N/A 6/30/2023 858 576 291 360 N/A 3/31/2023 822 528 267 340 N/A 12/31/2022 786 479 242 319 N/A 9/30/2022 745 447 261 326 N/A 6/30/2022 704 415 281 332 N/A 3/31/2022 697 436 343 384 N/A 12/31/2021 690 457 405 436 N/A 9/30/2021 654 413 379 405 N/A 6/30/2021 617 369 353 374 N/A 3/31/2021 564 310 278 298 N/A 12/31/2020 511 250 203 221 N/A 9/30/2020 506 227 246 261 N/A 6/30/2020 500 204 290 301 N/A 3/31/2020 502 205 303 313 N/A 12/31/2019 503 206 316 326 N/A 12/31/2018 354 147 189 205 N/A 12/31/2017 248 118 N/A 143 N/A
Daha fazla göster
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 9997 'nin tahmini kazanç büyümesi (yıllık 14.3% ) tasarruf oranının ( 2.3% ) üzerindedir.
Kazançlar ve Piyasa: 9997 şirketinin kazançlarının (yıllık 14.3% ) Hong Kong pazarından (yıllık 11.9% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: 9997 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde .
Gelir ve Pazar: 9997 şirketinin gelirinin (yıllık 15.9% ) Hong Kong pazarından (yıllık 7.8% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Geliri: 9997 şirketinin gelirinin (yıllık 15.9% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 9997 'un Özsermaye Getirisi 'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok
Büyüyen şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}